Evidence map›Paper›PMID 40621601›Full record

ArticleBioinformatics advances2025

Leveraging generative AI to assist biocuration of medical actions for rare disease.

Enock Niyonkuru, J Harry Caufield, Leigh C Carmody, Michael A Gargano, Sabrina Toro, Patricia L Whetzel, Hannah Blau, Mauricio Soto Gomez, Elena Casiraghi, Leonardo Chimirri and 5 more

Abstract read
In one paragraph

Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. AI semantics for biomedical data integration.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
  4. ChatGPT in precision medicine.APL bioengineering · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Enock NiyonkuruTrinity College, Hartford, CT 06106, United States.
J Harry CaufieldDivision of Environmental Genomics and Systems Biology, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, United States.ORCID https://orcid.org/0000-0001-5705-7831
Leigh C CarmodyThe Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, United States.
Michael A GarganoThe Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, United States.
Sabrina ToroDepartment of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
Patricia L WhetzelDepartment of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
Hannah BlauThe Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, United States.ORCID https://orcid.org/0000-0003-4557-5492
Mauricio Soto GomezAnacletoLab, Computer Science Department, Dipartimento di Informatica, Università degli Studi di Milano, Milan 20133, Italy.
Elena CasiraghiDivision of Environmental Genomics and Systems Biology, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, United States.ORCID https://orcid.org/0000-0003-2024-7572
Leonardo ChimirriBerlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin 10117, Germany.
Justin T ReeseDivision of Environmental Genomics and Systems Biology, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, United States.ORCID https://orcid.org/0000-0002-2170-2250
Giorgio ValentiniAnacletoLab, Computer Science Department, Dipartimento di Informatica, Università degli Studi di Milano, Milan 20133, Italy.ORCID https://orcid.org/0000-0002-5694-3919
Melissa A HaendelDepartment of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.ORCID https://orcid.org/0000-0001-9114-8737
Christopher J MungallDivision of Environmental Genomics and Systems Biology, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, United States.ORCID https://orcid.org/0000-0002-6601-2165
Peter N RobinsonThe Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, United States.ORCID https://orcid.org/0000-0002-0736-9199

Funding

The Monarch Initiative: Linking Diseases to Model Organism ResourcesR24OD011883 · OD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HAENDEL, MELISSA A, MUNGALL, CHRISTOPHER J · 2012 to 2024
$16.0M
Improvements to the LinkML framework to support the Phenomics First open science resourceRM1HG010860 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HAENDEL, MELISSA A, MUNGALL, CHRISTOPHER J · 2020 to 2024
$10.3M
The Human Phenotype Ontology: Accelerating Computational Integration of Clinical Data for GenomicsU24HG011449 · NHGRI · JACKSON LABORATORY · PI Peter Nicholas Robinson · 2021 to 2026
$6.7M
NHGRI NIH HHS RM1 HG010860NHGRI NIH HHS U24 HG011449NIH HHS R24 OD011883
6 · The paper itself

Abstract

Motivation: Structured representations of clinical data can support computational analysis of individuals and cohorts, and ontologies representing disease entities and phenotypic abnormalities are now commonly used for translational research. The Medical Action Ontology (MAxO) provides a computational representation of treatments and other actions taken for clinical management. Currently, manual biocuration is used to annotate MAxO terms to rare diseases. However, it is challenging to scale manual curation to comprehensively capture information about medical actions for the more than 10 000 rare diseases. Results: We present AutoMAxO, a semi-automated workflow that leverages Large Language Models (LLMs) to streamline MAxO biocuration. AutoMAxO first uses LLMs to retrieve candidate curations from abstracts of relevant publications. Next, the candidate curations are matched to ontology terms from MAxO, Human Phenotype Ontology (HPO), and MONDO disease ontology via a combination of LLMs and post-processing techniques. Finally, the matched terms are presented in a structured form to a human curator for approval. We used this approach to process abstracts related to 37 rare genetic diseases and identified 958 novel treatment annotations that were transferred to the MAxO annotation dataset. Availability and implementation: AutoMAxO is a Python package freely available at https://github.com/monarch-initiative/automaxo.

Identifiers

PMID40621601
PMCPMC12228962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.